DR. MICHAEL JOSEPH FAZIO, M.D.

SACRAMENTO, CA

Research Active
Dermatology - MOHS-Micrographic Surgery NPI registered 21+ years 50 publications 2021 – 2026 NPI: 1730185695
PrognosisArtificial IntelligenceSurveys and QuestionnairesVisual AcuityMultiple MyelomaTomography, Optical CoherenceGlaucomaIntraocular PressureRetinal DegenerationTelemedicineVision DisordersVisual FieldsHematologic NeoplasmsHemophilia ARetinal Ganglion Cells

Practice Location

1525 RESPONSE RD
SACRAMENTO, CA 95815-4801

Phone: (916) 492-1828

What does MICHAEL FAZIO research?

Dr. Fazio studies a variety of conditions and treatments, particularly in the areas of blood cancers like multiple myeloma and chronic myeloid leukemia, as well as the impact of vitamin D and advancements in artificial intelligence on patient care. He examines how different therapies and biological markers can improve health outcomes for patients undergoing treatments like stem cell transplants or cancer therapies. His work also explores the effects of dietary factors and gut health on treatment responses, providing a holistic view of how various factors influence patient health.

Key findings

  • In a study on stem cell transplantation, Dr. Fazio emphasized that patients should achieve at least 30 nanograms of vitamin D per milliliter within 30 days post-transplant to improve immune recovery and reduce complications.
  • In treating newly diagnosed multiple myeloma patients who are ineligible for a transplant, the combination therapy of daratumumab, lenalidomide, and dexamethasone resulted in a 90% response rate, with 59% of patients showing significant improvements.
  • Research on chronic myeloid leukemia identified the T315I mutation as a significant challenge for treatment, but new therapies are being developed that could improve outcomes for affected patients.

Frequently asked questions

Does Dr. Fazio study blood cancers?
Yes, Dr. Fazio conducts extensive research on blood cancers, including multiple myeloma and chronic myeloid leukemia.
What treatments has Dr. Fazio researched for multiple myeloma?
He has studied a combination treatment involving daratumumab, lenalidomide, and dexamethasone, which has shown promising results for patients who can't undergo a stem cell transplant.
Is Dr. Fazio's work relevant to patients with chronic myeloid leukemia?
Absolutely, his research specifically addresses treatment challenges in chronic myeloid leukemia, including mutations that complicate patient outcomes.

Publications in plain English

Stability of a standardized preparation of methotrexate, cytarabine, and methylprednisolone hemisuccinate for intrathecal use.

2026

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Perego G, Longobardo G, Viganò L, Locatelli A, Veneziano C +1 more

Plain English
This study looked at how stable a mixture of three cancer drugs—methotrexate, cytarabine, and methylprednisolone hemisuccinate—remains when prepared for injection into the spine. Researchers found that the drug mixture stayed stable for up to 24 hours, with no degradation greater than 10% and consistent pH levels, which means it is safe to use within that timeframe. This is important because it indicates that healthcare providers can prepare these medications ahead of time without compromising their effectiveness. Who this helps: This benefits patients receiving intrathecal treatments for cancer.

PubMed

Is Bruton tyrosine kinase a potential target to treat mast cell neoplasms? Systemic mastocytosis associated with chronic lymphoid leukemia successfully treated with acalabrutinib monotherapy: a case report and review of the literature.

2026

Haematologica

Fazio M, Elena C, Ferrari J, Camilotto V, Stella S +4 more

PubMed

Skeletal Involvement in Systemic Mastocytosis: Pathophysiology, Clinical Management, Standards of Care, and Novel Therapeutic Strategies.

2026

Cells

Fazio M, Bottaro A, Nasso ME, Stagno F, Allegra A

Plain English
This study looked at the effects of systemic mastocytosis, a condition where certain immune cells called mast cells grow too much, on the bones. It found that this disease can lead to severe bone problems, particularly in young men, causing conditions like osteoporosis and hardening of the bones. New treatments, especially a medication called avapritinib, can reverse these bone issues, and the study emphasizes the importance of early detection and personalized care to improve patients' overall health and prevent fractures. Who this helps: This helps patients with systemic mastocytosis and their doctors.

PubMed

Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients-A Survey from Two Italian Centers.

2026

Diseases (Basel, Switzerland)

Del Fabro V, Gullo L, Giunta G, Uccello G, Bellofiore C +11 more

Plain English
This study looked at how effective a treatment combining daratumumab, lenalidomide, and dexamethasone (called D-Rd) is for patients newly diagnosed with multiple myeloma who cannot undergo a stem cell transplant. They found that 90% of the 96 patients responded to the treatment, with 59% experiencing significant improvements, and many patients showed promising long-term survival results. This matters because it highlights D-Rd as a strong option for better outcomes in treating multiple myeloma, even as new treatments develop. Who this helps: This helps patients with newly diagnosed multiple myeloma who are not eligible for a transplant.

PubMed

Neuronal expression of Retinoid-Related Orphan Receptor Gamma (RORγ) and revisiting its role in the Central Nervous System.

2026

bioRxiv : the preprint server for biology

Reid L, Ganapathiraju S, Mancinelli S, Kagan D, Sprouse G +7 more

Plain English
This research studied a protein called RORγ, which has been thought to mainly exist in the immune system but is now found to also be present in brain cells, suggesting it plays a key role in brain development and function. The researchers discovered that RORγ is active in brain neurons during the early stages of development, but not in adult brains, and that removing this protein from certain brain cells can lead to serious issues like seizures. This finding is important because it changes the understanding of how RORγ affects the brain and could impact how we approach neurological diseases. Who this helps: This helps patients with neurological conditions and the doctors treating them.

PubMed

Vitamin D and Hemopoietic Stem Cell Transplantation: Clinical Guidance for GVHD Management and Post-Transplant Outcomes.

2026

Cancers

Fazio M, Nasso ME, Gangemi S, Bottaro A, Gammeri L +2 more

Plain English
The study looked at how vitamin D affects patients undergoing stem cell transplants, particularly focusing on preventing complications like graft-versus-host disease (GVHD). Researchers found that many patients have low vitamin D levels during this crucial period, impacting their immune recovery and increasing risks of infections and other issues. They recommend ensuring patients have at least 30 nanograms of vitamin D per milliliter by 30 days post-transplant to improve health outcomes and reduce complications. Who this helps: This helps patients undergoing stem cell transplants and their doctors.

PubMed

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

2026

Physical review letters

Abac AG, Abouelfettouh I, Acernese F, Ackley K, Adamcewicz C +1778 more

Plain English
Scientists analyzed the gravitational wave signal GW250114 — the strongest ever detected — to test whether the black hole produced by the merger behaves exactly as Einstein's general relativity predicts. The analysis confirmed at least two distinct oscillation modes in the signal and measured their frequencies to within a few percent of theoretical predictions, providing the most stringent single-event test of general relativity to date. These results validate both the theory and the Kerr description of black holes with unprecedented precision.

PubMed

Inhibitor Eradication in Postpartum Acquired Haemophilia A: Real-Life Case Series and Literature Review.

2025

Haemophilia : the official journal of the World Federation of Hemophilia

Giuffrida G, Markovic U, Grasso S, Duminuco A, Santuccio G +10 more

Plain English
This study looked at 15 women who developed a rare bleeding disorder called acquired hemophilia A after giving birth, from 2007 to 2023. The researchers found that while most patients (93%) managed to permanently get rid of the inhibitors causing their bleeding after an average of 28 days, many had to use immunosuppressive treatments for over 2 months. This is important because it shows that while some women may recover quickly from this condition, others may require extended treatment and face challenges in managing their symptoms effectively. Who this helps: This helps postpartum women affected by hemophilia A and their healthcare providers.

PubMed

Cost-Effective Bimetallic Catalysts for Green HProduction in Anion Exchange Membrane Water Electrolyzers.

2025

Nanomaterials (Basel, Switzerland)

Campagna Zignani S, Fazio M, Pascale M, Alessandrello C, Triolo C +2 more

Plain English
This research focused on creating low-cost materials that can improve the production of green hydrogen from water. The scientists developed new types of electrode materials (made of nickel and cobalt or nickel and iron) using a simple process and tested how well they performed. They found that their best electrode could generate a strong electrical current of 1 A when connected to a power source, maintaining good performance over a long period of 150 hours. Who this helps: This benefits companies and researchers working to create sustainable energy solutions.

PubMed

Artificial Intelligence in the Management of Hereditary and Acquired Hemophilia: From Genomics to Treatment Optimization.

2025

International journal of molecular sciences

Giordano L, Pagana AG, Minciullo PL, Fazio M, Stagno F +3 more

Plain English
This study examined how artificial intelligence (AI) can improve the management of hemophilia, a bleeding disorder either inherited or acquired due to immune system issues. Researchers found that AI can predict bleeding risks, tailor treatments, and monitor disease more effectively, leading to better detection of complications like joint damage. This matters because it can lead to faster, more accurate diagnoses and help improve patients’ lives by reducing long-term issues. Who this helps: Patients with hemophilia.

PubMed

Modeling the Bone Marrow Niche in Multiple Myeloma: From 2D Cultures to 3D Systems.

2025

International journal of molecular sciences

Bottaro A, Nasso ME, Stagno F, Fazio M, Allegra A

Plain English
This study focused on improving models for researching multiple myeloma, a type of blood cancer affecting plasma cells in the bone marrow. Researchers compared traditional two-dimensional cell cultures with three-dimensional systems that better mimic the bone marrow environment, finding that the 3D models offered more accurate insights into how the disease develops and how it resists treatments. Specifically, these 3D systems were better at predicting how new drugs would perform, which is crucial for developing effective therapies for patients. Who this helps: This research benefits patients with multiple myeloma by paving the way for more effective treatments.

PubMed

Oxidative Stress and Mitochondrial Dysfunction in Myelodysplastic Syndrome: Roles in Development, Diagnosis, Prognosis, and Treatment.

2025

International journal of molecular sciences

Pierro F, Fazio M, Murdaca G, Stagno F, Gangemi S +1 more

Plain English
This research looked at myelodysplastic syndromes (MDS), which are blood disorders where the bone marrow doesn't produce enough healthy blood cells and may lead to leukemia. The study found that high levels of oxidative stress—harmful molecules that cause damage—are linked to more cell death in the blood-forming cells, worsening the disease, and potentially leading to leukemia. Importantly, targeting oxidative stress with antioxidant treatments could improve patient outcomes and enhance existing therapies. Who this helps: This helps patients with myelodysplastic syndromes and their doctors in finding better treatment options.

PubMed

Septic Shock in Hematological Malignancies: Role of Artificial Intelligence in Predicting Outcomes.

2025

Current oncology (Toronto, Ont.)

Alvaro ME, Caserta S, Stagno F, Fazio M, Gangemi S +2 more

Plain English
This research studied how artificial intelligence (AI) can predict and improve outcomes for patients with hematologic cancers facing septic shock, a serious condition caused by infections. The study found that AI models analyzing health records and real-time data outperformed traditional methods, predicting sepsis risk with high accuracy, particularly using simple blood markers—like lactate levels—showing a cost-effective way to identify mortality risks. Using AI could lead to faster diagnosis and better treatment plans, potentially reducing death rates and ICU stays for these vulnerable patients. Who this helps: Patients with blood cancers at risk of septic shock.

PubMed

Decoding Immunodeficiencies with Artificial Intelligence: A New Era of Precision Medicine.

2025

Biomedicines

Sciaccotta R, Barone P, Murdaca G, Fazio M, Stagno F +3 more

Plain English
This study looked at how artificial intelligence (AI) can help detect and manage immune system problems that make people more susceptible to infections and diseases. Researchers found that using AI tools can lead to faster diagnoses and better treatments by analyzing patient data more effectively. For example, AI can help spot patterns in test results that might otherwise go unnoticed, resulting in quicker care and improved outcomes for patients. Who this helps: This benefits patients with immune deficiencies and their doctors by providing quicker, tailored treatment options.

PubMed

Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies.

2025

Non-coding RNA

Fazio M, Stagno F, Penna G, Mirabile G, Allegra A

Plain English
This research paper looked at tiny particles called exosomes, which cells release into the body. The study focused on how these exosomes, especially their microRNA content, can be important for diagnosing and monitoring blood cancers. It highlighted that while microRNAs can provide useful information about the disease, there are challenges in how they are collected and tested. Who this helps: This helps patients with blood cancers and their doctors by offering a potential new way to diagnose and track the disease.

PubMed

Gut Microbiota Dysbiosis and Dietary Interventions in Non-Hodgkin B-Cell Lymphomas: Implications for Treatment Response.

2025

Biomedicines

Caserta S, Alvaro ME, Penna G, Fazio M, Stagno F +1 more

Plain English
This study looked at how the balance of bacteria in the gut (gut microbiota) affects the treatment of Non-Hodgkin B-cell lymphomas, a type of cancer. Researchers found that an unhealthy gut microbiome, which is common in these patients, can disrupt the immune system and make treatments less effective, especially when antibiotics are used. They also identified certain beneficial bacteria that could help improve treatment responses, highlighting the potential for dietary changes and other interventions to enhance patient outcomes. Who this helps: This helps patients with Non-Hodgkin B-cell lymphomas.

PubMed

Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted Therapy.

2025

International journal of molecular sciences

Badagliacca R, Fazio M, Stagno F, Mirabile G, Gerace D +1 more

Plain English
This research looked at curcumin, a natural compound found in turmeric, and its effects on acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. The study found that curcumin can help kill cancer cells, slow their growth, and improve blood vessel formation in tumors, showing promise when combined with existing treatments. However, curcumin has low absorption in the body, but new methods are being developed to improve this. Who this helps: This research benefits patients with acute myeloid leukemia and their doctors by offering potential new treatment options.

PubMed

Expert consensus on essential characteristics of oncology value-based payment.

2025

The American journal of managed care

Fazio M, Henschel R, Lyss AJ, Mehring K, Trivedi S +3 more

Plain English
Researchers studied different payment models in cancer care to find out how to make them better for patients while controlling costs. They found that effective models should focus on patient needs, adjust for risks appropriately, and have measures specific to cancer outcomes. Although some existing payment methods are popular, they are criticized for being outdated and hard to manage, especially for small practices. Improving these models is crucial for ensuring high-quality cancer care while also making it more affordable and equitable. Who this helps: Patients and healthcare providers in oncology.

PubMed

Chronic Myeloid Leukemia and the T315IMutation.

2025

International journal of molecular sciences

Pierro F, Stella S, Fazio M, Russo S, Massimino M +4 more

Plain English
This research paper looks at a specific mutation called T315I in patients with chronic myeloid leukemia (CML), a type of cancer that affects blood cells. The T315I mutation makes it harder for common treatments, known as tyrosine kinase inhibitors (TKIs), to work, leading to worse outcomes for patients. The study reviews current knowledge about this mutation, discusses treatment options, and explores new strategies to address the challenges it presents. Who this helps: This helps patients with chronic myeloid leukemia and their doctors by providing insights into treatment options for those with the T315I mutation.

PubMed

Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia.

2025

Diagnostics (Basel, Switzerland)

Russo S, Fazio M, Mirabile G, Sciaccotta R, Stagno F +1 more

Plain English
This study looked at a rare complication called bone marrow edema (BME) in patients with chronic myeloid leukemia (CML) who were treated with tyrosine kinase inhibitors (TKIs). The researchers described three cases where patients developed BME while on TKI therapy, which improved after stopping the medication or switching to a different treatment. Recognizing and managing BME is crucial, as it can cause severe damage to the bones if not addressed promptly. Who this helps: This helps patients with chronic myeloid leukemia and their doctors by improving awareness and management of a potential side effect of treatment.

PubMed

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

2025

Physical review letters

Abac AG, Abouelfettouh I, Acernese F, Ackley K, Adamcewicz C +1777 more

Plain English
The gravitational wave event GW250114 was detected with exceptional signal strength, making it the loudest gravitational wave observed so far. Analysis of the post-merger signal confirmed it matches the predicted vibrations of a Kerr black hole, and Hawking's area law — which says black hole surface area cannot decrease — was verified to high confidence. The event provides an unusually precise single-observation test of general relativity.

PubMed

Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Baseline Results.

2024

American journal of ophthalmology

Owsley C, Swain TA, McGwin G, Nghiem VTH, Register S +5 more

Plain English
The study examined the effectiveness of a telemedicine program in Alabama that screened patients for eye health issues, particularly glaucoma, at community health centers. Out of 500 participants, about 30% were found to have glaucoma-related diseases, nearly 38% had cataracts, and 47% were referred for follow-up care, with an impressive follow-up attendance rate of 76.7%. This is important because it shows that using telemedicine can effectively identify eye problems and help ensure that patients receive necessary treatment in their local communities. Who this helps: This benefits patients at community health centers who are at risk for eye diseases.

PubMed

Time to Glaucoma Progression Detection by Optical Coherence Tomography in Individuals of African and European Descents.

2024

American journal of ophthalmology

Wu JH, Moghimi S, Walker E, Nishida T, Brye N +6 more

Plain English
This study looked at how quickly doctors can find signs of glaucoma progression using a technology called optical coherence tomography (OCT) in patients of African and European descent. The research found that while the time to detect changes in the eye's nerve fiber layer thickness was similar for both groups when conditions were equal, patients of African descent had a faster thinning rate of nerve fibers, leading to earlier detection of glaucoma progression (4.8 years for African descent patients compared to 5.4 years for European descent patients). This is important because it suggests that tailored monitoring could help catch glaucoma progression earlier in patients of African descent. Who this helps: Patients with glaucoma, especially those of African descent.

PubMed

FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive Women.

2024

Pathogens (Basel, Switzerland)

Peronace C, Cione E, Abrego-Guandique DM, Fazio M, Panduri G +3 more

Plain English
This study looked at the DNA changes in two specific genes, FAM19A4 and hsa-miR124-2, in women who had abnormal cervical cell results linked to high-risk HPV infections. The researchers found that 75% of women with Atypical Squamous Cells of Uncertain Significance (ASC-H) and 60% of women with low-grade lesions (CIN1) showed changes in these genes. These findings are important because identifying such DNA changes early can help manage these women’s health and prevent the development of cervical cancer. Who this helps: This helps women with high-risk HPV infections and their doctors.

PubMed

Norepinephrine Salt Formulations and Risk of Therapeutic Error: Results of a National Survey.

2024

Journal of cardiothoracic and vascular anesthesia

Salvati S, D'Andria Ursoleo J, Belletti A, Monti G, Bonizzoni MA +2 more

Plain English
This study looked at how well doctors and nurses in Italian hospitals understand the difference between the active form of norepinephrine (the drug used for severe low blood pressure) and its salt form, which is often labeled on drug packages. Out of 106 healthcare professionals surveyed, more than half (53%) thought that guidelines showed doses in the salt form, leading to confusion that resulted in 81% of them making incorrect dose calculations. This matters because these errors can be dangerous for patients receiving treatment. Who this helps: This helps patients who rely on accurate dosing for their treatment.

PubMed

Three-Way Translocation t(12;15;17) (p13;q24;q21) Found in Acute Promyelocytic Leukemia with Basophilic Differentiation.

2024

Hematology reports

Frazzetto S, Gullo L, Sapuppo G, Fazio M, Lo Faro C +12 more

Plain English
This study examined a rare form of leukemia called acute promyelocytic leukemia, focusing on a patient who had an unusual genetic change involving three chromosomes (12, 15, and 17). Despite the overall association of this genetic change with a worse outcome, the patient responded very well to standard treatments and achieved complete remission. This finding highlights that even in complex cases with poor prognostic features, patients can still respond effectively to established therapies. Who this helps: This benefits patients with acute promyelocytic leukemia and their doctors by providing insights into possible treatment responses.

PubMed

Association of Shift-Level Organizational Factors with Nosocomial Infection in the Neonatal Intensive Care Unit.

2024

Journal of pediatrics. Clinical practice

Fazio M, Jabbour E, Patel S, Bertelle V, Lapointe A +6 more

Plain English
This study looked at how certain aspects of hospital organization—like how many nurses are working and how much overtime they put in—affect the rate of infections in very premature babies in the neonatal intensive care unit (NICU). The researchers found that 11.5% of the infants studied developed infections, and more nursing overtime increased the risk of infections (with a minimal increase of 8% for every 1% increase in overtime), while having more nurses than recommended lowered that risk. These results highlight the importance of proper staffing and work hours to protect vulnerable infants from infections in the NICU. Who this helps: This helps patients and healthcare providers working in neonatal intensive care.

PubMed

IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects.

2024

Hematology reports

Fazio M, Sorbello CMC, Del Fabro V, Romano A, Cannizzaro MT +6 more

Plain English
This study examined a patient with a type of cancer called extramedullary multiple myeloma, focusing on how it changed over time. The patient first had a specific tumor pattern that then changed into a different form of the cancer, which may affect treatment choices and outcomes. The researchers believe that the patterns of certain proteins in the cancer cells can help predict how well a patient will do and should be considered when assessing risk. Who this helps: This helps doctors in treating patients with advanced multiple myeloma.

PubMed

CAD/CAM-based 3D-printed and PVS indirect bonding jig system accuracy: a systematic review, meta-analysis, and comparative analysis of hard and soft CAD/CAM transfer trays.

2024

European journal of orthodontics

Palone M, Fazio M, Pellitteri F, Guiducci D, Cremonini F +3 more

Plain English
This study looked at the accuracy of two types of dental trays used in orthodontics: CAD/CAM (computer-aided design/computer-aided manufacturing) trays and PVS (polyvinylsiloxane) trays. It found that CAD/CAM trays had an average positioning error of about 0.075 mm for certain measurements and were generally less accurate than PVS trays, with soft CAD/CAM trays being more accurate than hard ones. This research is important because accurate bracket positioning is crucial for effective orthodontic treatment, which directly impacts patient outcomes. Who this helps: Patients receiving orthodontic treatment.

PubMed

Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide.

2023

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Perego G, Longobardo G, Baldisserotto A, Feliciani M, Fazio M

PubMed

Technologies to support the diagnosis and/or treatment of neurodevelopmental disorders: A systematic review.

2023

Neuroscience and biobehavioral reviews

Previously Marzena Szkodo MOR, Micai M, Caruso A, Fulceri F, Fazio M +1 more

Plain English
Researchers looked at how technology is being used to diagnose and treat neurodevelopmental disorders (NDDs), focusing mainly on Autism Spectrum Disorder (ASD). They found 221 studies showing that tools like machine learning and brain imaging techniques have potential for improving diagnosis and treatment, but many studies had issues that may affect their reliability. This development is important because it could lead to better support for individuals with NDDs, enhancing their care and outcomes. Who this helps: Patients with neurodevelopmental disorders and their healthcare providers.

PubMed

Association of Rates of Ganglion Cell and Inner Plexiform Thinning With Development of Glaucoma in Eyes With Suspected Glaucoma.

2023

JAMA ophthalmology

Mohammadzadeh V, Moghimi S, Nishida T, Walker E, Kamalipour A +8 more

Plain English
This study looked at how quickly certain layers of the eye thin out in people who are suspected of having glaucoma and whether this thinning is connected to developing actual glaucoma over time. Researchers followed 462 participants for about three years and found that the eyes that developed glaucoma showed faster thinning rates: on average, -1.28 micrometers per year compared to -0.66 micrometers per year in those who did not develop glaucoma. Each micrometer-per-year increase in thinning increased the risk of developing glaucoma by 2.4 times for one layer and 1.9 times for another layer. Who this helps: Patients at risk for glaucoma can benefit from better monitoring to prevent vision loss.

PubMed

Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.

2023

American journal of ophthalmology

Moghimi S, Kamalipour A, Nishida T, Zangwill L, Fazio M +3 more

Plain English
This study looked at how the severity of vision loss in glaucoma patients affects their quality of life over about 10 years. Researchers found that patients who started with worse vision had lower quality of life scores, and those who experienced faster vision loss saw their quality of life decline even more. For example, vision measurements from the better eye were linked to poorer quality of life outcomes, showing a stronger relationship than measurements from the worse eye. Who this helps: This research benefits glaucoma patients by highlighting the importance of monitoring their vision to understand and manage their quality of life better.

PubMed

Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma.

2023

Journal of glaucoma

Wu JH, Moghimi S, Nishida T, Kamalipour A, Liebmann JM +4 more

Plain English
This study looked at how changes in central vision fields relate to the loss of sharpness in vision among people with mild to moderate glaucoma. Researchers followed 252 eyes over nearly six years and found that those with faster declines in central visual field measurements were much more likely to experience vision loss; specifically, those with quicker declines had up to eight times the risk of losing visual acuity. This is important because it suggests that regularly monitoring central vision changes can help predict and potentially prevent vision loss in glaucoma patients. Who this helps: Patients with glaucoma.

PubMed

Clinical Factors Associated With Long-Term OCT Variability in Glaucoma.

2023

American journal of ophthalmology

Wu JH, Moghimi S, Walker E, Nishida T, Liebmann JM +4 more

Plain English
This study looked at how different factors affect the variability in the thickness of the retinal nerve fiber layer in glaucoma patients over time. Researchers analyzed data from 1,140 eyes belonging to 634 patients and found that certain factors, like being African American, having cataract or glaucoma surgery, and experiencing a faster thinning rate were linked to greater variability in measurements. On the other hand, having more frequent check-ups led to more stable measurements, which is important because consistent monitoring can help better track the progression of glaucoma. Who this helps: This helps patients with glaucoma and their doctors by improving how they monitor and manage the disease.

PubMed

A case of high-risk AML in a patient with advanced systemic mastocytosis.

2023

Clinical case reports

Fazio M, Vetro C, Markovic U, Duminuco A, Parisi M +11 more

Plain English
This study examined a patient with a severe form of leukemia known as acute myeloid leukemia (AML) combined with advanced systemic mastocytosis, a condition involving an overproduction of mast cells. The researchers found that a powerful treatment combining three drugs—decitabine, venetoclax, and midostaurin—only had a temporary effect on the AML and a reduced impact on the mastocytosis. Understanding these limitations is important because it highlights the need for more effective treatments for patients with these complex conditions. Who this helps: This helps patients suffering from high-risk AML and systemic mastocytosis.

PubMed

Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience.

2023

Clinical therapeutics

Duminuco A, Fazio M, Grasso S, Gullo L, Riccobene C +4 more

Plain English
This study looked at the effectiveness and safety of a drug called eliglustat in treating Gaucher disease (GD) by following 12 patients at one medical center. After at least 12 months of treatment, patients showed significant reductions in two important markers related to the disease: chitotriosidase decreased from 394.3 to 181.1 nmol/h/mL, and glucosylsphingosine dropped from 45.1 to 18.9 ng/mL. There were no serious safety issues with the drug, and most side effects were mild and temporary, which is important for improving patient quality of life. Who this helps: This benefits patients with Gaucher disease and their doctors by providing a safe and effective treatment option.

PubMed

Permeability evolution of Bentheim Sandstone at simulated georeservoir conditions.

2023

Scientific reports

Fazio M, Chandler MR, Sauter M

Plain English
This study looked at how the ability of Bentheim Sandstone to let fluids flow through it changes with depth, simulating real underground conditions. The researchers found that as the rock gets deeper—up to about 2-3 kilometers—the permeability decreases, but then partially recovers at depths of 4-5 kilometers. Understanding how permeability varies with depth is important because it helps in accurately estimating how fluids move in geological formations, which is crucial for oil and gas exploration. Who this helps: This helps geologists and energy companies involved in resource extraction.

PubMed

Multiple Myeloma in 2023 Ways: From Trials to Real Life.

2023

Current oncology (Toronto, Ont.)

Fazio M, Del Fabro V, Parrinello NL, Allegra A, Markovic U +13 more

Plain English
This research paper focuses on multiple myeloma, a type of blood cancer that often comes back after treatment. The study reviews how new medications, developed from recent research, have been tested in clinical trials and their effectiveness in real-life situations. It highlights that therapies like T-cell engagers and CAR-T cells are showing promise for helping patients with advanced-stage disease, potentially improving results for many. Who this helps: This benefits patients with multiple myeloma and their healthcare providers.

PubMed

Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging.

2022

Nucleic acid therapeutics

Mukherjee P, Aksamitiene E, Alex A, Shi J, Bera K +8 more

Plain English
This study looked at how well two different types of antisense oligonucleotides (ASOs), which are designed to target and modify gene expression, are taken up by liver cells (hepatocytes) and immune cells (macrophages) in mice. Researchers found that while both types of ASOs were taken up by macrophages at similar rates, the liver-targeted ASOs (GalNAc-PS-ASOs) were taken up more effectively by hepatocytes, leading to 30% more internalization compared to the standard ASOs. This matters because improving how ASOs are delivered can enhance their effectiveness in treating liver diseases. Who this helps: Patients with liver-related conditions.

PubMed

LinguAPP: An m-Health Application for Teledentistry Diagnostics.

2022

International journal of environmental research and public health

Fazio M, Lombardo C, Marino G, Marya A, Messina P +4 more

Plain English
The study focused on a new mobile app called LinguAPP that helps diagnose dental issues using simple questionnaires and photos, making it accessible for anyone, even those without a lot of experience. Developed quickly during the COVID-19 pandemic, the app has been used across Italy to provide dental support remotely, which is important for reducing the need for in-person visits. This can help keep patients safe while still addressing their dental health needs. Who this helps: This benefits patients who need dental care without visiting a clinic.

PubMed

Recent Considerations on Gaming Console Based Training for Multiple Sclerosis Rehabilitation.

2022

Medical sciences (Basel, Switzerland)

Celesti A, Cimino V, Naro A, Portaro S, Fazio M +2 more

Plain English
This study looked at whether using a Nintendo Wii Fit Balance Board could help people with Multiple Sclerosis (MS) improve their physical abilities and overall quality of life during rehabilitation. The results showed that patients who used the Wii Fit as part of their training experienced better physical improvements compared to those who followed a standard rehabilitation program. This matters because it highlights new, fun ways to support MS patients in regaining their mobility and independence through innovative technology. Who this helps: This benefits patients with Multiple Sclerosis and their rehabilitation providers.

PubMed

Accuracy evaluation of orthodontic movements with aligners: a prospective observational study.

2022

Progress in orthodontics

Bilello G, Fazio M, Amato E, Crivello L, Galvano A +1 more

Plain English
This study looked at how accurately clear aligners (like Invisalign) move teeth into place during orthodontic treatment. The results showed that, on average, aligners achieved about 86% accuracy in rotating teeth, with the best results for certain teeth being as high as 98%. This is important because it helps patients and doctors understand how effective these aligners can be in creating the desired smile and may guide better treatment planning. Who this helps: Patients seeking orthodontic treatment with clear aligners.

PubMed

Exploring the impact of mobility restrictions on the COVID-19 spreading through an agent-based approach.

2022

Journal of transport & health

Fazio M, Pluchino A, Inturri G, Le Pira M, Giuffrida N +1 more

Plain English
This study examined how limiting people's movements affected the spread of COVID-19 in Italy. Researchers created a model that predicted that if local areas had tailored restrictions based on their specific risk factors, they could reduce infections and deaths significantly. They found that without these targeted measures, infections could rise by 20% and deaths by 25%. This matters because it highlights the need for local policies that balance health safety with economic impact during a pandemic. Who this helps: This helps public health officials and policymakers design more effective pandemic response strategies.

PubMed

Non-invasive Imaging of Antisense Oligonucleotides in the Brain via In Vivo Click Chemistry.

2022

Molecular imaging and biology

Cook BE, Archbold J, Nasr K, Girmay S, Goldstein SI +13 more

Plain English
This study focused on a new way to visualize how therapeutic drugs, specifically antisense oligonucleotides (ASOs), disperse in the brain after they are injected. Researchers created a special imaging tool that can track these drugs without invasive procedures, showing that the tool successfully delivered the ASO to the brain in animal tests. The findings are exciting because they can lead to better dosing and effectiveness of treatments for neurological diseases, which are often hard to manage. Who this helps: This helps patients with neurological conditions who need effective treatments.

PubMed

The Effects of Low-frequency Vibration on Aligner Treatment Duration: A Clinical Trial.

2022

Journal of International Society of Preventive & Community Dentistry

Bilello G, Fazio M, Currò G, Scardina GA, Pizzo G

Plain English
This study looked at how a device called AcceleDent affects the time it takes to complete orthodontic treatment with aligners. Patients using AcceleDent changed their aligners every 7 days and finished treatment in about 9 days per aligner, while those without the device took about 15 days per aligner. This is important because using AcceleDent not only sped up treatment but also helped reduce pain for patients. Who this helps: This benefits patients undergoing orthodontic treatment with aligners.

PubMed

The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.

2022

Biomedicines

Peronace C, Tallerico R, Colosimo M, Fazio M, Pasceri F +11 more

Plain English
This study focused on a new variant of the SARS-CoV-2 virus called Omicron BA.4, identified for the first time in Italy. Researchers found that this variant carries a unique mutation not seen in earlier variants, which could give it an advantage in spreading and reducing the effectiveness of vaccines; specifically, it has mutations in the spike and nucleocapsid proteins that may allow it to evade detection by common tests. Understanding this variant is crucial because it could become a major concern as it spreads. Who this helps: This research benefits public health officials and doctors who need to monitor and respond to emerging COVID-19 variants.

PubMed

Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

2022

Physical review letters

Abbott R, Abbott TD, Acernese F, Ackley K, Adams C +1413 more

Plain English
This study looked for pairs of small black holes in data from two gravitational wave observatories, Advanced LIGO and Advanced Virgo, collected from April to October 2019. The researchers didn’t find any strong evidence for these small black holes merging, but they determined that if they do exist, they could merge at rates between 220 and 24,200 times per billion light-years each year. This is important because it provides new limits on the potential types of dark matter that could include small black holes, helping us understand more about the universe. Who this helps: This helps astrophysicists and researchers studying dark matter.

PubMed

Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.

2021

Thrombosis research

Bolzacchini E, Pomero F, Fazio M, Civitelli C, Fabro G +3 more

Plain English
This research looked at whether a specific treatment for advanced breast cancer, known as CDK 4/6 inhibitors, increases the risk of blood clots in women. They found that women taking CDK 4/6 inhibitors had a two to three times greater chance of developing venous blood clots compared to those receiving standard hormone therapy without these inhibitors. However, the risk of arterial blood clots was only slightly higher and not statistically significant. Who this helps: This information is valuable for patients with advanced breast cancer and their doctors, as it highlights important risks associated with certain treatments.

PubMed

Do neurosurgeons follow the guidelines? A world-based survey on severe traumatic brain injury.

2021

Journal of neurosurgical sciences

Saraceno G, Servadei F, Terzi DI Bergamo L, Iaccarino C, Rubiano AM +34 more

Plain English
This study looked at how well neurosurgeons follow guidelines for treating severe traumatic brain injuries (TBI) in different countries. Researchers surveyed 803 neurosurgeons, finding that 73% in low-income countries (LMICs) used hypertonic solutions early in treatment compared to 65% in high-income countries (UHICs). They also discovered that procedures like intracranial pressure monitoring and surgery were done sooner in LMICs. Who this helps: This helps patients with severe traumatic brain injuries and their doctors by highlighting the need for better guidelines that consider different healthcare resources.

PubMed

Frequent Co-Authors

Fabio Stagno Alessandro Allegra Francesco Di Raimondo Christopher A Girkin Sebastiano Gangemi Alessandra Romano Sasan Moghimi Takashi Nishida Jeffrey M Liebmann Robert N Weinreb

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.